series-c-plus
Stage
2010
Founded
3
Investors
About
Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells.
Explore Verastem's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.